デフォルト表紙
市場調査レポート
商品コード
1790336

北米の造影剤注入器市場規模、シェア、動向分析:製品タイプ別、最終用途別、地域別、セグメント予測、2025年~2033年

North America Contrast Media Injectors Market Size, Share & Trends Analysis By Product (Injector Systems, Consumables), By Type, By Application (Radiology, Interventional Cardiology), By End-use, By Region, And Segment Forecasts, 2025 - 2033


出版日
ページ情報
英文 110 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
北米の造影剤注入器市場規模、シェア、動向分析:製品タイプ別、最終用途別、地域別、セグメント予測、2025年~2033年
出版日: 2025年07月09日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の造影剤注入器市場の概要

北米の造影剤注入器市場規模は、2024年に8億936万米ドルと推定され、2033年には18億2,890万米ドルに達すると予測され、2025~2033年のCAGRは9.69%で成長すると予測されます。北米の造影剤注入器の需要は、MRI、CTスキャン、血管造影などの画像検査のニーズが高まっていることに加え、シリンジレス注入器のような先進技術の採用が拡大していることから増加しています。

米国とカナダにおける医療用画像診断の需要の高まりが市場成長の原動力となっています。Canadian Medical Imaging Inventory(CMII)報告書のデータによると、カナダでは2022~2023年に約6,385,665件のCT検査が実施され、人口1,000人当たり平均160.2件の検査が実施されました。このような大量の画像検査により、今後数年間は造影剤注入装置の需要が増加すると予想されます。

さらに、がんや心臓病などの慢性疾患の有病率の増加は、北米の造影剤注入器産業の成長を大きく促進すると予想されています。米国国立医療図書館によると、2025年5月、米国在住の成人のCAD有病率は2022年までの3年間で4.6%から4.9%に上昇し、先進的心血管イメージングを必要とする患者人口が増加していることを示しています。

同様に、カナダのがん罹患率も著しく増加しています。Canadian Medical Association Journalが発表したデータによると、カナダでは2024年に約247,100人の新規がん患者が発生すると予測されています。このような疾病負担の増加により、CTスキャンやMRIのような精密で効率的な画像診断技術に対する需要が高まっており、これらの技術は画像の鮮明度を高めるために造影剤注入装置に大きく依存しています。その結果、北米のヘルスケアプロバイダは、診断精度と患者の転帰を改善するために革新的な造影剤注入システムに投資しており、市場拡大に拍車をかけています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米の造影剤注入器市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 北米の造影剤注入器市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 北米の造影剤注入器市場:製品別、推定・動向分析

  • セグメントダッシュボード
  • 北米の造影剤注入器市場の製品変動分析
  • 北米の造影剤注入器市場規模と動向分析(製品別、2021~2033年)
  • 注入器システム
  • 消耗品

第5章 北米の造影剤注入器市場:タイプ別、推定・動向分析

  • セグメントダッシュボード
  • 北米の造影剤注入器市場のタイプ変動分析
  • 北米の造影剤注入器市場規模と動向分析(タイプ別、2021~2033年)
  • シングルヘッド注入器
  • デュアルヘッド注入器
  • シリンジレス注入器

第6章 北米の造影剤注入器市場:用途別、推定・動向分析

  • セグメントダッシュボード
  • 北米の造影剤注入器市場の用途変動分析
  • 北米の造影剤注入器市場規模と動向分析(用途別、2021~2033年)
  • 放射線科
  • インターベンショナルカーディオロジー
  • インターベンショナルラジオロジー

第7章 北米の造影剤注入器:最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 北米の造影剤注入器市場の最終用途変動分析
  • 北米の造影剤注入器市場規模と動向分析(最終用途別、2021~2033年)
  • 病院
    • 市場推定・予測、2021~2033年
  • 診断センター
    • 市場推定・予測、2021~2033年
  • 外来手術センター
    • 市場推定・予測、2021~2033年

第8章 北米の造影剤注入器市場:地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測と動向分析、2021~2033年
  • 北米
    • 米国
    • カナダ
    • メキシコ

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
    • Bracco Diagnostics Inc.
    • Shenzhen Boon Medical Supply Co., Ltd.
    • Bayer Corporation
    • Guerbet LLC
    • B. Braun Medical Inc.
    • ulrich GmbH & Co. KG
    • Shenzhen Antmed Co., Ltd.
    • Ecomed Solutions
    • Siemens Medical Solutions USA, Inc
  • ヒートマップ分析/企業市況分析
  • 2024年の企業市場シェア予測分析
  • その他の主要市場参入企業一覧
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America North America Contrast Media Injectors Market, By Country, 2021 - 2033 (USD Million)
  • Table 4 North America North America Contrast Media Injectors Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 North America North America Contrast Media Injectors Market, By Type, 2021 - 2033 (USD Million)
  • Table 6 North America North America Contrast Media Injectors Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America North America Contrast Media Injectors Market, By Application, 2021 - 2033 (USD Million)
  • Table 8 U.S. North America Contrast Media Injectors Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 U.S. North America Contrast Media Injectors Market, By Type, 2021 - 2033 (USD Million)
  • Table 10 U.S. North America Contrast Media Injectors Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. North America Contrast Media Injectors Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 Canada North America Contrast Media Injectors Market, By Product, 2021 - 2033 (USD Million)
  • Table 13 Canada North America Contrast Media Injectors Market, By Type, 2021 - 2033 (USD Million)
  • Table 14 Canada North America Contrast Media Injectors Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 Canada North America Contrast Media Injectors Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Mexico North America Contrast Media Injectors Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico North America Contrast Media Injectors Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico North America Contrast Media Injectors Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Mexico North America Contrast Media Injectors Market, By Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 North America Contrast Media Injectors Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 North America Contrast Media Injectors Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 15 North America Contrast Media Injectors Market, for Injector Systems, 2021 - 2033 (USD Million)
  • Fig. 16 North America Contrast Media Injectors Market, for Consumables, 2021 - 2033 (USD Million)
  • Fig. 17 North America Contrast Media Injectors Market, for CT Injector Systems, 2021 - 2033 (USD Million)
  • Fig. 18 North America Contrast Media Injectors Market, for MRI Injector Systems, 2021 - 2033 (USD Million)
  • Fig. 19 North America Contrast Media Injectors Market, for Cardiovascular/Angiography Injector Systems, 2021 - 2033 (USD Million)
  • Fig. 20 North America Contrast Media Injectors Market, for Syringes, 2021 - 2033 (USD Million)
  • Fig. 21 North America Contrast Media Injectors Market, for Tubings, 2021 - 2033 (USD Million)
  • Fig. 22 North America Contrast Media Injectors Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 23 North America Contrast Media Injectors Market, for Type, 2021 - 2033 (USD Million)
  • Fig. 24 North America Contrast Media Injectors Market, for Single Head Injectors, 2021 - 2033 (USD Million)
  • Fig. 25 North America Contrast Media Injectors Market, for Double Head Injectors, 2021 - 2033 (USD Million)
  • Fig. 26 North America Contrast Media Injectors Market, for Syringeless injectors, 2021 - 2033 (USD Million)
  • Fig. 27 North America Contrast Media Injectors Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 28 North America Contrast Media Injectors Market, for Radiology, 2021 - 2033 (USD Million)
  • Fig. 29 North America Contrast Media Injectors Market, for Interventional Cardiology 4, 2021 - 2033 (USD Million)
  • Fig. 30 North America Contrast Media Injectors Market, for Interventional Radiology, 2021 - 2033 (USD Million)
  • Fig. 31 North America Contrast Media Injectors Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 32 North America Contrast Media Injectors Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 33 North America Contrast Media Injectors Market, for Diagnostic Centers, 2021 - 2033 (USD Million)
  • Fig. 34 North America Contrast Media Injectors Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Contrast Media Injectors Market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada Contrast Media Injectors Market, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico Contrast Media Injectors Market, 2021 - 2033 (USD Million)
目次
Product Code: GVR-4-68040-664-1

North America Contrast Media Injectors Market Summary

The North America contrast media injectors market size was estimated at USD 809.36 million in 2024 and is projected to reach USD 1,828.90 million by 2033, growing at a CAGR of 9.69% from 2025 to 2033. The demand for contrast media injectors in North America is increasing due to the rising need for imaging tests such as MRI, CT scans, and angiography, along with the growing adoption of advanced technologies like syringeless injectors.

The growing demand for medical imaging in the U.S. and Canada is driving market growth. Data from the Canadian Medical Imaging Inventory (CMII) report indicates that approximately 6,385,665 CT exams were conducted, averaging 160.2 exams per 1,000 people in Canada in 2022-2023. This high volume of imaging procedures is expected to increase the demand for contrast media injectors in the coming years.

Furthermore, the increasing prevalence of chronic diseases such as cancer and heart disease is expected to significantly drive the growth of the North America contrast media injectors industry. According to the National Library of Medicine, in May 2025, the prevalence of CAD among adults living in the U.S. rose from 4.6% to 4.9% within 3 years till 2022, indicating a growing patient population requiring advanced cardiovascular imaging.

Similarly, cancer incidence in Canada is significantly increasing. According to data published by the Canadian Medical Association Journal, approximately 247,100 new cancer cases are projected for Canada in 2024. This rising disease burden is increasing the demand for precise and efficient diagnostic imaging techniques such as CT scans and MRIs, which rely heavily on contrast media injectors to enhance image clarity. As a result, healthcare providers across North America are investing in innovative contrast injector systems to improve diagnostic accuracy and patient outcomes, fueling market expansion.

North America Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America contrast media injectors market report based on product, type, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Injector systems
    • CT injector systems
    • MRI injector systems
    • Cardiovascular/angiography injector systems
  • Consumables
    • Syringes
    • Tubings
    • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Single-head injectors
  • Dual head injectors
  • Syringeless injectors
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiology
  • Interventional cardiology
  • Interventional radiology
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostics centers
  • Ambulatory surgery centers
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Type
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Contrast Media Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for imaging tests
      • 3.2.1.2. Rising launches and approvals of contrast media injectors
      • 3.2.1.3. Increasing prevalence of chronic disorders
      • 3.2.1.4. Growing adoption of syringeless injectors
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Potential complications and risks associated with contrast media injections
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Rising number of distribution agreements
      • 3.2.3.2. Advancements in contrast media injectors
      • 3.2.3.3. Growing clinical trials for contrast media and injectors
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of radiologists and healthcare professionals
  • 3.3. North America Contrast Media Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. North America Contrast Media Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Contrast Media Injectors Market Product Movement Analysis
  • 4.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Injector systems
    • 4.4.1. Injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.1. CT injector systems
        • 4.4.1.1.1. CT injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.2. MRI injector systems
        • 4.4.1.2.1. MRI injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.3. Cardiovascular/angiography injector systems
        • 4.4.1.3.1. Cardiovascular/angiography injector systems market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.1. Syringes
        • 4.5.1.1.1. Syringes market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.2. Tubings
        • 4.5.1.2.1. Tubings market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.3. Others
        • 4.5.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. North America Contrast Media Injectors Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Contrast Media Injectors Market Type Movement Analysis
  • 5.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Single head injectors
    • 5.4.1. Single head injectors market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.5. Dual head injectors
    • 5.5.1. Dual head injectors market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.6. Syringeless injectors
    • 5.6.1. Syringeless injectors market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. North America Contrast Media Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America Contrast Media Injectors Market Application Movement Analysis
  • 6.3. North America Contrast Media Injectors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Radiology
    • 6.4.1. Radiology market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.5. Interventional cardiology
    • 6.5.1. Interventional cardiology market estimates and forecasts for 2021 to 2033 (USD Million)
  • 6.6. Interventional radiology
    • 6.6.1. Interventional radiology market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. North America Contrast Media Injectors Devices: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America Contrast Media Injectors Market End Use Movement Analysis
  • 7.3. North America Contrast Media Injectors Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.5. Diagnostics centers
    • 7.5.1. Diagnostics centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 7.6. Ambulatory Surgery Centers
    • 7.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. North America Contrast Media Injectors Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Bracco Diagnostics Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Shenzhen Boon Medical Supply Co., Ltd.
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Bayer Corporation
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Guerbet LLC
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. B. Braun Medical Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. ulrich GmbH & Co. KG,
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Shenzhen Antmed Co., Ltd.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Ecomed Solutions
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Siemens Medical Solutions USA, Inc
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
  • 9.4. Heat Map Analysis/ Company Market Position Analysis
  • 9.5. Estimated Company Market Share Analysis, 2024
  • 9.6. List of Other Key Market Players